FAM
VIVO

Fenimore Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Fenimore Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-264,900
Closed -$5.44M – 108
2015
Q4 		$5.44M Hold
264,900
– – 0.28% 63
2015
Q3 		$4.53M Buy
264,900
+20,000
+8% +$366K 0.24% 69
2015
Q2 		$4.57M Buy
244,900
+84,100
+52% +$1.56M 0.24% 68
2015
Q1 		$3.07M Buy
160,800
+96,299
+149% +$1.78M 0.16% 72
2014
Q4 		$1.06M Buy
+64,501
New +$1.11M 0.05% 87

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Fenimore Asset Management's VIVO Position: Q1 2016 in Review

Fenimore Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2016, closing a stake of 264,900 shares — an estimated $5.44M sold.

Fenimore Asset Management first reported a position in VIVO in Q4 2014 and held it in 5 quarters. The position peaked at $5.44M in Q4 2015. 172 funds tracked by Wall St. Rank hold VIVO as of Q1 2016.

  • Fenimore Asset Management reported no remaining Meridian Bioscience Inc position as of Q1 2016 after selling out during the quarter.
  • Fenimore Asset Management sold 264,900 Meridian Bioscience Inc shares in Q1 2016, an estimated $5.44M.
  • Fenimore Asset Management first reported a position in Meridian Bioscience Inc in Q4 2014 and held it in 5 quarters.
  • Fenimore Asset Management's Meridian Bioscience Inc position peaked at $5.44M in Q4 2015.
  • 172 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2016.

Based on Fenimore Asset Management's 13F filing for Q1 2016, filed 8 Apr 2016.